

Publisher: John Wiley & Sons Inc
E-ISSN: 2163-8306|5|8|411-417
ISSN: 2163-8306
Source: Cpt: Pharmacometrics & Systems Pharmacology, Vol.5, Iss.8, 2016-08, pp. : 411-417
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




By Suematsu Fumihiro Yukawa Eiji Yukawa Miho Minemoto Masao Ohdo Shigehiro Higuchi Shun Goto Yoshinobu
European Journal of Clinical Pharmacology, Vol. 57, Iss. 1, 2001-04 ,pp. :




Experience with Remifentanil in Neonates and Infants
Drugs, Vol. 66, Iss. 10, 2006-01 ,pp. :